Johnson & Johnson released data showing a booster dose of its one-shot COVID-19 vaccine generates a stronger immune response and a robust increase in antibodies. According to data from the pharmaceutical company, the extra shot provides 94% protection against the...
The situation around the current spread of COVID-19 is changing rapidly. We have compiled resource links for the general community highlighting local resources across New Jersey, ways to get involved, and mental and physical wellness. Visit our COVID-19 page for...
Pfizer said Monday data from a new trial show its COVID-19 vaccine is safe for kids ages 5 to 11, and it will file with regulators as soon as possible for expanded approval. Pfizer said kids in the trial had a similar antibody response to young adults ages 16 to 25 in...
Researchers have been studying how much care American adults will require as they age, and for how long. For years, researchers have tried to calculate what proportion of the aging population will need such extensive care. A 2019 study found that over their lifetimes,...
Please read Dr. Jimenez’s article in the Journal of Allergy and Clinical Immunology titled, “Black and Latinx Community Perspectives on COVID-19 Mitigation Behaviors, Testing, and Vaccines.” As of May 2021, the US has the highest number of cases and...
